Correlation between virus persistent infection and cardic function in patients with dilated cardiomyopathy

Qiang Liu1, Xiao-jia Su, Yan Yu

  • 1Department of Cardiology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310006, China. LQ_925@163.com

Insights

Dilated cardiomyopathy (DCM) patients often have persistent coxsackie virus B-RNA (CVB-RNA) infections. Increased coxsackie adenovirus receptor (CAR) expression correlates with DCM severity and can indicate persistent viral infection.

Area of Science:

  • Cardiology
  • Virology
  • Molecular Biology

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
  • Persistent viral infections, particularly enteroviruses like coxsackievirus B, are implicated in DCM pathogenesis.
  • The role of viral persistence and specific cellular receptors in DCM requires further elucidation.

Purpose of the Study:

  • To investigate the prevalence of persistent coxsackie virus B-RNA (CVB-RNA) in DCM patients.
  • To examine the expression levels of the coxsackie adenovirus receptor (CAR) in DCM patients and its correlation with viral infection and cardiac function.
  • To assess the potential of CAR as a biomarker for persistent viral infection in DCM.

Main Methods:

  • Fifty DCM patients and a control group were analyzed.
  • Coxsackie virus B-RNA (CVB-RNA) presence was detected using molecular methods.
  • Expression levels of coxsackie adenovirus receptor (CAR) were quantified.
  • Cardiac function was assessed by measuring brain natriuretic peptide (BNP), left ventricular ejection fraction (LVEF), and left ventricular end-diastolic diameter (LVEDd).

Main Results:

  • 44% of DCM patients were CVB-RNA positive, compared to 20% in controls (P<0.05).
  • CAR expression was significantly higher in DCM patients than in controls (P<0.01).
  • CVB-RNA positive patients exhibited higher CAR expression than CVB-RNA negative patients (P<0.01).
  • CAR expression positively correlated with BNP levels but not with LVEF or LVEDd.

Conclusions:

  • Persistent CVB-RNA infection is prevalent in DCM.
  • Elevated CAR expression is associated with persistent viral infection and cardiac dysfunction in DCM.
  • CAR expression on white blood cells serves as a potential indicator for detecting persistent viral infections in DCM.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...